S&P 500   4,354.98 (+0.12%)
DOW   34,293.17 (+0.37%)
QQQ   344.17 (-0.12%)
AAPL   160.34 (+0.41%)
MSFT   300.54 (+1.29%)
FB   297.00 (+0.80%)
GOOGL   2,599.55 (+0.58%)
AMZN   2,814.27 (+1.33%)
TSLA   856.94 (-8.58%)
NVDA   220.13 (-3.33%)
BABA   112.20 (-1.03%)
NIO   21.41 (-5.52%)
AMD   103.85 (-6.20%)
CGC   6.94 (-4.01%)
MU   79.73 (-2.73%)
GE   88.61 (-0.79%)
T   24.01 (-0.99%)
F   19.71 (-1.00%)
DIS   135.23 (+1.22%)
AMC   14.84 (-6.90%)
PFE   53.75 (+1.40%)
ACB   3.86 (-4.93%)
BA   190.97 (-1.70%)
S&P 500   4,354.98 (+0.12%)
DOW   34,293.17 (+0.37%)
QQQ   344.17 (-0.12%)
AAPL   160.34 (+0.41%)
MSFT   300.54 (+1.29%)
FB   297.00 (+0.80%)
GOOGL   2,599.55 (+0.58%)
AMZN   2,814.27 (+1.33%)
TSLA   856.94 (-8.58%)
NVDA   220.13 (-3.33%)
BABA   112.20 (-1.03%)
NIO   21.41 (-5.52%)
AMD   103.85 (-6.20%)
CGC   6.94 (-4.01%)
MU   79.73 (-2.73%)
GE   88.61 (-0.79%)
T   24.01 (-0.99%)
F   19.71 (-1.00%)
DIS   135.23 (+1.22%)
AMC   14.84 (-6.90%)
PFE   53.75 (+1.40%)
ACB   3.86 (-4.93%)
BA   190.97 (-1.70%)
S&P 500   4,354.98 (+0.12%)
DOW   34,293.17 (+0.37%)
QQQ   344.17 (-0.12%)
AAPL   160.34 (+0.41%)
MSFT   300.54 (+1.29%)
FB   297.00 (+0.80%)
GOOGL   2,599.55 (+0.58%)
AMZN   2,814.27 (+1.33%)
TSLA   856.94 (-8.58%)
NVDA   220.13 (-3.33%)
BABA   112.20 (-1.03%)
NIO   21.41 (-5.52%)
AMD   103.85 (-6.20%)
CGC   6.94 (-4.01%)
MU   79.73 (-2.73%)
GE   88.61 (-0.79%)
T   24.01 (-0.99%)
F   19.71 (-1.00%)
DIS   135.23 (+1.22%)
AMC   14.84 (-6.90%)
PFE   53.75 (+1.40%)
ACB   3.86 (-4.93%)
BA   190.97 (-1.70%)
S&P 500   4,354.98 (+0.12%)
DOW   34,293.17 (+0.37%)
QQQ   344.17 (-0.12%)
AAPL   160.34 (+0.41%)
MSFT   300.54 (+1.29%)
FB   297.00 (+0.80%)
GOOGL   2,599.55 (+0.58%)
AMZN   2,814.27 (+1.33%)
TSLA   856.94 (-8.58%)
NVDA   220.13 (-3.33%)
BABA   112.20 (-1.03%)
NIO   21.41 (-5.52%)
AMD   103.85 (-6.20%)
CGC   6.94 (-4.01%)
MU   79.73 (-2.73%)
GE   88.61 (-0.79%)
T   24.01 (-0.99%)
F   19.71 (-1.00%)
DIS   135.23 (+1.22%)
AMC   14.84 (-6.90%)
PFE   53.75 (+1.40%)
ACB   3.86 (-4.93%)
BA   190.97 (-1.70%)
NASDAQ:XRAY

DENTSPLY SIRONA Stock Forecast, Price & News

$52.69
+0.18 (+0.34%)
(As of 01/27/2022 12:46 PM ET)
Add
Compare
Today's Range
$52.69
$53.68
50-Day Range
$48.31
$57.18
52-Week Range
$48.13
$69.54
Volume
18,077 shs
Average Volume
1.45 million shs
Market Capitalization
$11.52 billion
P/E Ratio
27.73
Dividend Yield
0.83%
Beta
0.93
30 days | 90 days | 365 days | Advanced Chart
Receive XRAY News and Ratings via Email

Sign-up to receive the latest news and ratings for DENTSPLY SIRONA and its competitors with MarketBeat's FREE daily newsletter.


DENTSPLY SIRONA logo

About DENTSPLY SIRONA

Dentsply Sirona, Inc. engages in the design, manufacture, sales and distribution of professional dental products and technologies. It operates through the following segments: Technologies and Equipment and Consumables. The Technologies and Equipment segments comprises dental technology, equipment and healthcare consumable products such as dental implants, laboratory dental products, computer-aided design and computer-aided manufacturing systems, imaging systems, treatment centers and consumable medical device products. The Consumables segment offers preventive, restorative, instruments, endodontic and orthodontic dental products. The company was founded in 1899 and is headquartered in Charlotte, NC.

Headlines

DaVita's (DVA) Collaboration to Aid in Kidney Care Needs
January 26, 2022 |  finance.yahoo.com
See More Headlines

Industry, Sector and Symbol

Industry
Dental equipment & supplies
Sub-Industry
Health Care Supplies
Sector
Medical
Current Symbol
NASDAQ:XRAY
CUSIP
24903010
Employees
15,200
Year Founded
2016

Sales & Book Value

Annual Sales
$3.34 billion
Cash Flow
$3.98 per share
Book Value
$22.74 per share

Profitability

Net Income
$-83 million
Pretax Margin
12.81%

Debt

Price-To-Earnings

Miscellaneous

Free Float
217,099,000
Market Cap
$11.52 billion
Optionable
Optionable

Company Calendar

Last Earnings
11/04/2021
Ex-Dividend for 1/14 Dividend
12/30/2021
Dividend Payable
1/14/2022
Today
1/27/2022
Next Earnings (Estimated)
3/07/2022
Fiscal Year End
12/31/2022

Social Links


MarketRank

Overall MarketRank

3.33 out of 5 stars

Medical Sector

12th out of 1,420 stocks

Dental Equipment & Supplies Industry

1st out of 5 stocks

Analyst Opinion: 3.2Community Rank: 4.3Dividend Strength: 3.3Insider Behavior: 3.3Valuation: 2.5 5 -4 -3 -2 -1 -












DENTSPLY SIRONA (NASDAQ:XRAY) Frequently Asked Questions

Is DENTSPLY SIRONA a buy right now?

5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for DENTSPLY SIRONA in the last twelve months. There are currently 1 sell rating, 1 hold rating and 3 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" DENTSPLY SIRONA stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in XRAY, but not buy additional shares or sell existing shares.
View analyst ratings for DENTSPLY SIRONA
or view top-rated stocks.

How has DENTSPLY SIRONA's stock price been impacted by COVID-19 (Coronavirus)?

DENTSPLY SIRONA's stock was trading at $42.56 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, XRAY stock has increased by 23.8% and is now trading at $52.69.
View which stocks have been most impacted by COVID-19
.

Are investors shorting DENTSPLY SIRONA?

DENTSPLY SIRONA saw a increase in short interest in December. As of December 31st, there was short interest totaling 3,000,000 shares, an increase of 27.1% from the December 15th total of 2,360,000 shares. Based on an average trading volume of 1,730,000 shares, the short-interest ratio is presently 1.7 days. Currently, 1.4% of the shares of the company are sold short.
View DENTSPLY SIRONA's Short Interest
.

When is DENTSPLY SIRONA's next earnings date?

DENTSPLY SIRONA is scheduled to release its next quarterly earnings announcement on Monday, March 7th 2022.
View our earnings forecast for DENTSPLY SIRONA
.

How were DENTSPLY SIRONA's earnings last quarter?

DENTSPLY SIRONA Inc. (NASDAQ:XRAY) issued its quarterly earnings results on Thursday, November, 4th. The medical instruments supplier reported $0.68 earnings per share (EPS) for the quarter, topping the Thomson Reuters' consensus estimate of $0.65 by $0.03. The medical instruments supplier had revenue of $1.07 billion for the quarter, compared to analysts' expectations of $1.02 billion. DENTSPLY SIRONA had a trailing twelve-month return on equity of 13.05% and a net margin of 9.85%. The firm's revenue was up 19.4% compared to the same quarter last year. During the same quarter last year, the firm earned $0.67 EPS.
View DENTSPLY SIRONA's earnings history
.

How often does DENTSPLY SIRONA pay dividends? What is the dividend yield for DENTSPLY SIRONA?

DENTSPLY SIRONA announced a quarterly dividend on Thursday, December 16th. Stockholders of record on Friday, December 31st will be paid a dividend of $0.11 per share on Friday, January 14th. This represents a $0.44 annualized dividend and a yield of 0.84%. The ex-dividend date of this dividend is Thursday, December 30th.
View DENTSPLY SIRONA's dividend history
.

Is DENTSPLY SIRONA a good dividend stock?

DENTSPLY SIRONA pays an annual dividend of $0.44 per share and currently has a dividend yield of 0.83%. DENTSPLY SIRONA has been increasing its dividend for 11 consecutive years, indicating the company has a strong committment to maintain and grow its dividend. The dividend payout ratio of DENTSPLY SIRONA is 23.16%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, DENTSPLY SIRONA will have a dividend payout ratio of 13.84% next year. This indicates that DENTSPLY SIRONA will be able to sustain or increase its dividend.
View DENTSPLY SIRONA's dividend history.

What guidance has DENTSPLY SIRONA issued on next quarter's earnings?

DENTSPLY SIRONA issued an update on its FY 2021 earnings guidance on Thursday, November, 18th. The company provided earnings per share guidance of $2.870-$2.920 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $2.880. The company issued revenue guidance of $4.25 billion-$4.30 billion, compared to the consensus revenue estimate of $4.29 billion.

What price target have analysts set for XRAY?

5 brokers have issued 12 month price objectives for DENTSPLY SIRONA's stock. Their forecasts range from $55.00 to $79.00. On average, they expect DENTSPLY SIRONA's share price to reach $70.60 in the next twelve months. This suggests a possible upside of 34.0% from the stock's current price.
View analysts' price targets for DENTSPLY SIRONA
or view top-rated stocks among Wall Street analysts.

Who are DENTSPLY SIRONA's key executives?

DENTSPLY SIRONA's management team includes the following people:
  • Don M. Casey, Chief Executive Officer & Director
  • Jorge M. Gomez, Chief Financial Officer & Executive Vice President
  • Cord F. Stähler, Chief Technology Officer & Senior Vice President
  • Keith J. Ebling, Secretary, Executive VP & General Counsel
  • Markus Boehringer, Senior Vice President

What is Don Casey's approval rating as DENTSPLY SIRONA's CEO?

105 employees have rated DENTSPLY SIRONA CEO Don Casey on Glassdoor.com. Don Casey has an approval rating of 70% among DENTSPLY SIRONA's employees.

What other stocks do shareholders of DENTSPLY SIRONA own?

Based on aggregate information from My MarketBeat watchlists, some companies that other DENTSPLY SIRONA investors own include NVIDIA (NVDA), Intel (INTC), QUALCOMM (QCOM), Boeing (BA), General Electric (GE), International Business Machines (IBM), Broadcom (AVGO), Comcast (CMCSA), Gilead Sciences (GILD) and Tesla (TSLA).

What is DENTSPLY SIRONA's stock symbol?

DENTSPLY SIRONA trades on the NASDAQ under the ticker symbol "XRAY."

Who are DENTSPLY SIRONA's major shareholders?

DENTSPLY SIRONA's stock is owned by many different retail and institutional investors. Top institutional investors include Wedge Capital Management L L P NC (0.29%), Hardman Johnston Global Advisors LLC (0.22%), Nordea Investment Management AB (0.13%), New York State Teachers Retirement System (0.11%), John G Ullman & Associates Inc. (0.11%) and Boston Trust Walden Corp (0.07%). Company insiders that own DENTSPLY SIRONA stock include Donald M Jr Casey, Eric Brandt, Gregory T Lucier, Lisa Yankie, Michael C Alfano, Walter Petersohn, William E Newell and Willie A Deese.
View institutional ownership trends for DENTSPLY SIRONA
.

Which major investors are selling DENTSPLY SIRONA stock?

XRAY stock was sold by a variety of institutional investors in the last quarter, including State of Alaska Department of Revenue, Janney Montgomery Scott LLC, Sepio Capital LP, Hardman Johnston Global Advisors LLC, Russell Investments Group Ltd., Gulf International Bank UK Ltd, NN Investment Partners Holdings N.V., and Stonebridge Capital Management Inc.. Company insiders that have sold DENTSPLY SIRONA company stock in the last year include Eric Brandt, Lisa Yankie, and Walter Petersohn.
View insider buying and selling activity for DENTSPLY SIRONA
or view top insider-selling stocks.

Which major investors are buying DENTSPLY SIRONA stock?

XRAY stock was bought by a variety of institutional investors in the last quarter, including Wedge Capital Management L L P NC, Nordea Investment Management AB, John G Ullman & Associates Inc., Oak Thistle LLC, Clean Yield Group, Canvas Wealth Advisors LLC, Carnegie Capital Asset Management LLC, and Tokio Marine Asset Management Co. Ltd.. Company insiders that have bought DENTSPLY SIRONA stock in the last two years include Donald M Jr Casey, and Gregory T Lucier.
View insider buying and selling activity for DENTSPLY SIRONA
or or view top insider-buying stocks.

How do I buy shares of DENTSPLY SIRONA?

Shares of XRAY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is DENTSPLY SIRONA's stock price today?

One share of XRAY stock can currently be purchased for approximately $52.69.

How much money does DENTSPLY SIRONA make?

DENTSPLY SIRONA has a market capitalization of $11.52 billion and generates $3.34 billion in revenue each year. The medical instruments supplier earns $-83 million in net income (profit) each year or $1.90 on an earnings per share basis.

How many employees does DENTSPLY SIRONA have?

DENTSPLY SIRONA employs 15,200 workers across the globe.

When was DENTSPLY SIRONA founded?

DENTSPLY SIRONA was founded in 2016.

What is DENTSPLY SIRONA's official website?

The official website for DENTSPLY SIRONA is www.dentsplysirona.com.

Where are DENTSPLY SIRONA's headquarters?

DENTSPLY SIRONA is headquartered at 13320 BALLANTYNE CORPORATE PLACE, CHARLOTTE NC, 28277.

How can I contact DENTSPLY SIRONA?

DENTSPLY SIRONA's mailing address is 13320 BALLANTYNE CORPORATE PLACE, CHARLOTTE NC, 28277. The medical instruments supplier can be reached via phone at (844) 848-0137, via email at [email protected], or via fax at 302-655-5049.


This page was last updated on 1/27/2022 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.